On Tuesday, Atossa Therapeutics Inc (NASDAQ: ATOS) opened lower -3.44% from the last session, before settling in for the closing price of $0.83. Price fluctuations for ATOS have ranged from $0.55 to $1.66 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 36.92% over the last five years. Company’s average yearly earnings per share was noted -16.25% at the time writing. With a float of $129.12 million, this company’s outstanding shares have now reached $129.17 million.
The firm has a total of 15 workers. Let’s measure their productivity. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Atossa Therapeutics Inc (ATOS) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Atossa Therapeutics Inc is 0.04%, while institutional ownership is 26.19%. The most recent insider transaction that took place on May 21 ’25, was worth 9,887. In this transaction President & CEO of this company bought 11,239 shares at a rate of $0.88, taking the stock ownership to the 13,898 shares. Before that another transaction happened on Mar 26 ’25, when Company’s Director bought 10,000 for $0.70, making the entire transaction worth $7,000. This insider now owns 10,257 shares in total.
Atossa Therapeutics Inc (ATOS) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around -16.25% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -14.47% during the next five years compared to 36.92% growth over the previous five years of trading.
Atossa Therapeutics Inc (NASDAQ: ATOS) Trading Performance Indicators
Check out the current performance indicators for Atossa Therapeutics Inc (ATOS). In the past quarter, the stock posted a quick ratio of 12.67.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.21, a number that is poised to hit -0.06 in the next quarter and is forecasted to reach -0.27 in one year’s time.
Technical Analysis of Atossa Therapeutics Inc (ATOS)
Analysing the last 5-days average volume posted by the [Atossa Therapeutics Inc, ATOS], we can find that recorded value of 0.86 million was lower than the volume posted last year of 0.89 million. As of the previous 9 days, the stock’s Stochastic %D was 9.01%.
During the past 100 days, Atossa Therapeutics Inc’s (ATOS) raw stochastic average was set at 48.78%, which indicates a significant increase from 2.72% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0500 in the past 14 days, which was lower than the 0.0558 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.8529, while its 200-day Moving Average is $0.9357.
